Press Releases
American Pacific Mining Identifies Large-Scale MT Anomaly at Madison Project with Drill Testing Underway
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2026) - American Pacific Mining Corp. (CSE: USGD) (OTCQX: USGDF) (FSE: 1QC) (WKN: A422L8) ("American Pacific", or the "Company") is pleased to announce that drill testing of a new priority target recently identified by a magnetotelluric ("MT") inversion survey at the Company's Madison Copper-Gold Project ("Madison" or the "Project") in Montana, is now underway. The large-scale, highly conductive geophysical anomaly is located in an area of the Project that has never been drill tested...
2026 Letter to Nano One Stakeholders
Nano One Materials Corp. ("Nano One" or the "Company") (TSX:NANO)(OTCQB:NNOMF)(Frankfurt:LBMB), a process technology company specializing in lithium-ion battery cathode active materials, provides a message to our stakeholders. To view this release in its original stylized PDF Clicks Here VANCOUVER, BC / ACCESS Newswire / June 3, 2026 / Opening Remarks from Board Chair To our Shareholders, Customers, Commercial and Government Partners, and Colleagues, Before Alex Holmes addresses you directly, I would like to offer a few remarks on behalf of the Board of Directors...
Herbal Dispatch Inc. Appoints Jason Spatafora as Strategic Advisor
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leading cannabis e-commerce and distribution platform, is pleased to announce the appointment of Jason Spatafora as a strategic advisor to the Company. The appointment comes as Herbal Dispatch continues its transformation into a scalable, technology-enabled cannabis distribution platform...
Apex Announces Drill Program Expansion and H2 Exploration Plans at the Rift Rare Earth Project
Highlights: The Company's recently closed $15,000,500 financing (See News Release June 2, 2026) provides the capital to significantly expand its ongoing drill program and exploration plans to accelerate the timeline to an inaugural mineral resource estimate (MRE) at Rift. To-date, ~12,000 m has been completed across 18 drillholes with assays reported for six (6) (assays pending for 12 holes)...
Dentsu extends Magnite partnership to streamline CTV activation across Sweden
Collaboration builds on existing partnership in EMEA to support more intelligent, efficient and transparent CTV activation across premium inventory Collaboration builds on existing partnership in EMEA to support more intelligent, efficient and transparent CTV activation across premium inventory
IQVIA Announces Offering of Senior Notes
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise €950,000,000 through an offering of senior notes due 2033 (the “Notes”). The proceeds from the Notes offering will be used to refinance certain of the Issuer's existing indebtedness and to pay fees and expenses related to the Notes offering. The consummation of the Notes offering is subject to market and other custo...
Autoliv Strengthens Global Safety Innovation
VÅRGÅRDA, Sweden, June 3, 2026 /PRNewswire/ -- Autoliv, Inc. (NYSE: ALV) (SSE: ALIVsdb), the worldwide leader in automotive safety systems, is taking a significant step to accelerate the development of life-saving mobility solutions through the Autoliv Innovation Center - a new global platform designed to speed up innovation, collaboration, and development of advanced safety technologies. The Autoliv Innovation Center is inaugurated today in Vårgårda, Sweden, the city where Autoliv's history began...
BW LPG Exits Investment in Confidence Petroleum India Following Sale of 8.50% Equity Stake
SINGAPORE--(BUSINESS WIRE)--BW LPG Limited (“BW LPG” or the “Company”, OSE ticker: “BWLPG.OL”) announces that it has completed the sale of its 8.50% equity stake in Confidence Petroleum India Limited (“CPIL” or “Confidence”, NSE Code: “CONFIPET”, BSE Code: “526829”). Following the announcement made on 20 May 2025 on BW LPG's cessation of investment in infrastructure, we have exited our various infrastructure partnership in India. Today, we sold our 8.5% equity position in CPIL, and the divestme...
RENEWAL OF THE AGREEMENT BETWEEN SCUDERIA FERRARI HP AND CHARLES LECLERC
Maranello (Italy), June 3, 2026 - Ferrari N.V. (NYSE/EXM: RACE) announces the multi-year renewal of the agreement between Scuderia Ferrari HP and Charles Leclerc.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - June 03
Purchase of own shares LONDON, UK / ACCESS Newswire / June 3, 2026 / The Company announces that on 02 June 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026...
Statkraft and Elkem sign seven-year power agreement for Bjølvefossen plant in Norway
(Oslo, Norway, 3 June 2026) Statkraft and Elkem ASA have signed a new long-term power purchase agreement (PPA) that secures competitive and predictable electricity supply for Elkem's plant in Bjølvefossen, Norway. The agreement is for the 2031-2037 period, and the total contract volume is 1,534 GWh. The agreement supports continued industrial activity, local value creation and sustainable production at Bjølvefossen. The plant employs 150 people and is one of the world's largest suppliers of foundry alloys, with an annual production capacity of 60.000 mt. Its products are sold primarily in the EU and Asia and are used in sectors such as automotive, construction, renewable energy and defence. They are produced with a carbon footprint of around one-third of the global average. “We are very pleased to sign yet another long-term power agreement with an important Norwegian industrial company. Long-term contracts at competitive terms help support local jobs and value creation at a time of significant uncertainty and volatility, says EVP Markets in Statkraft, Hallvard Granheim. “Access to long-term, competitive power agreements is essential to maintain industrial production and jobs in Norway. This agreement with Statkraft strengthens the competitiveness of our Bjølvefossen plant and reflects the close link between energy and industrial development in Norway. It enables us to continue supplying strategic materials to European industry and supporting the EU's security in a turbulent geopolitical context,” says Inge Grubben-Strømnes, Elkem's SVP Foundry Alloys. Elkem has a strong portfolio of long-term power contracts in Norway, securing a significant share of its 3.5 TWh annual power consumption at competitive terms. The new agreement further strengthens predictability for the company's operations and investment planning. For further information, please contact:
STMicroelectronics high-performance vibration sensor with in-sensor AI offers a compelling alternative to piezosensor to fast-growing industrial condition-monitoring market
STMicroelectronics high-performance vibration sensor with in-sensor AI offers a compelling alternative to piezosensor to fast-growing industrial condition-monitoring market
Wolters Kluwer and OpenAI expand enterprise AI collaboration to advance trusted Expert AI for regulated professionals
PRESS RELEASE Wolters Kluwer and OpenAI expand enterprise AI collaboration to advance trusted Expert AI for regulated professionals The collaboration combines OpenAI's latest capabilities across Wolters Kluwer's Expert AI product suite to accelerate next-generation AI for professionals in high-stakes fields Alphen aan den Rijn — June 3, 2026 — Wolters Kluwer , a global leader in Expert AI, AI-enabled software solutions, and professional information, has announced an expanded enterprise AI collaboration with OpenAI. This marks a broader effort and growing collaboration to develop and release AI native solutions that advance Expert AI for professionals and institutions operating in regulated, high-stakes environments...
Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care
Novo Nordisk is launching Wegovy pill in the UAE, the first country outside the US, to make the Wegovy pill available to people living with obesity
HAFNIA LIMITED: Ex dividend USD 0.2877 on the Oslo Stock Exchange today
SINGAPORE--(BUSINESS WIRE)--Reference is made to the stock exchange announcements made by Hafnia Limited ("Hafnia” or the "Company", OSE ticker code: “HAFNI”, NYSE ticker code: “HAFN”) on 27 May 2026 regarding key information relating to the dividend for the first quarter 2026. The Company's shares will be traded ex-dividend on the Oslo Stock Exchange as of today, 3 June 2026, and on the New York Stock Exchange as of 4 June 2026. About Hafnia Limited: Hafnia is one of the world's leading tanker...
argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren's Disease at EULAR 2026
ALKIVIA+ data in myositis indicate efgartigimod provides sustained, clinically meaningful improvements and consistent safety RHO+ data in Sjogren's disease indicate maintenance of response following switch to biweekly dosing Cross-indication analysis of efgartigimod data across rheumatology studies underscores consistent safety profile in large patient population June 3, 2026, 7:00 AM CEST Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced the presentation of new data evaluating VYVGART (IV: efgartigimod alfa-fcab and SC or Hytrulo: efgartigimod alfa and hyaluronidase-qvfc) across autoimmune rheumatic diseases, including myositis and Sjogren's disease, to be presented at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress from June 3-6, 2026, in London, UK. “Our presentations at EULAR further support the rationale for targeting FcRn in autoimmune rheumatic diseases and underscore its potential to address significant unmet patient need,” said Luc Truyen, M.D...
JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)
Warsaw, Poland – June 03, 2026 – JJP Biologics, ("JJPBio" or the "Company") a clinical-stage, immune-focused biotech that engineers precision antibodies to correct derailed immune pathways that drive autoimmune diseases and cancer, today announces positive interim data from its ongoing Phase 1b trial evaluating nebaprubart, also known as JJP-1212, its investigational potential first-in-class anti-CD89 antagonist, in patients diagnosed with Linear IgA Disease (LAD), a rare autoantibody-mediated skin disease...
Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study
Nipocalimab – the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and reduce pathogenic immunoglobulin G (IgG) autoantibodies associated with this disease while preserving immune function Results demonstrated significant reduction of systemic lupus erythematosus disease activity which continued beyond the 24-week primary endpoint, and were sustained through Week 52 in the nipocalimab 15 mg/kg groupa The ongoing Phase 3 study of nipocalimab is currently recruiting people living with systemic lupus erythematosus – a debilitating autoantibody-driven disease which can lead to systemic organ damage LONDON, June 3, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced nipocalimab met the primary endpoint of decreasing disease activity at 24 weeks as measured by SLE Responder Index 4 (SRI-4)b and continued to demonstrate sustained reduction in disease activity in adults with moderate-to-severe systemic lupus erythematosus (SLE)a through 52 weeks in the Phase 2 JASMINE study as measured by both SRI-4b and Lupus Low Disease Activity State (LLDAS).c In addition, the study results showed greater response versus placebo plus background medicationd in participants who tested positive for lupus-associated autoantibodies, which represents the vast majority (~80%) of people living with SLE.e,1 These findings will be featured in a late-breaking presentation at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress in London and are among the 38 abstracts the Company is presenting across its Rheumatology portfolio. Nipocalimab is designed to selectively block the neonatal Fc receptor (FcRn), reducing levels of circulating pathogenic immunoglobulin (IgG) autoantibodies and immune complexes associated with inflammation in SLE.2,3 By reducing circulating IgG, including autoantibodies, nipocalimab is designed to target the underlying cause of disease while preserving critical immune functions.4 JASMINE is the first clinical study to demonstrate efficacy of FcRn blockade in SLE and provides clinical, biomarker and pharmacodynamic evidence supporting the continued investigation of nipocalimab as a potential treatment option for this disease.5 A healthcare professional's perspective "The consistent improvements observed across established disease activity measures and reductions in pathogenic immunoglobulin G autoantibodies are encouraging and support the continued investigation of nipocalimab as a targeted treatment approach for people living with systemic lupus erythematosus," said Richard Furie, M.D...
Johnson & Johnson presents new data further reinforcing the role of nipocalimab in lowering the autoantibodies driving Sjögren's disease
Nipocalimab, an immunoselective neonatal Fc receptor (FcRn) blocker, is designed to target and reduce pathogenic immunoglobulin G (IgG) autoantibodies associated with Sjögren's disease while preserving immune function New exploratory analysis of Phase 2 study data shows a strong correlation between autoantibody levels and even greater clinical response rates of participants in the nipocalimab treatment group Previously reported data from the Phase 2 study showed nipocalimab reduced Sjögren's disease activity and severity, with potential to address systemic manifestations and the most burdensome patient-reported symptoms including dryness, fatigue and pain Nipocalimab is the only FcRn blocker granted both Breakthrough Therapy Designation and Fast Track Designation by the U.S. FDA for the treatment of adults with moderate-to-severe Sjögren's disease. LONDON, June 3, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced new biomarker exploratory analyses from the Phase 2 DAHLIAS study evaluating nipocalimab in adults with moderate-to-severe Sjögren's disease (SjD)a showing that participants with elevated autoantibody and immunoglobulin G (IgG) levelsb, who are often those who experience more substantial disease burden, showed greater clinical response rates.1 These data will be presented in an oral session at the 2026 European Alliance of Associations for Rheumatology (EULAR) Congress...
SEALSQ Participates as a Lead Investor in Quobly's €130 Million Series A Financing Via SEALQuantum.com Fund to Advance the European Sovereign Quantum Infrastructure
Geneva, Switzerland, June 03, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES), ("SEALSQ" or "Company"), a leader in post-quantum semiconductor technologies and hardware-anchored security solutions, today announced its participation as a lead investor in Quobly's €130 million Series A financing. The round is led by ST Microelectronics, SEALSQ, Isalt, and the French Public Investment Bank (BPI France)...
TETRA Technologies, Inc. Announces Pricing of Public Offering of Common Stock
SPRING, Texas, June 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) today announced the pricing of an underwritten public offering of 10,810,811 shares of its common stock, par value $0.01 per share ("Common Stock"), at a price to the public of $9.25 per share, pursuant to an effective shelf registration statement on Form S-3 (the "Registration Statement") filed with the U.S. Securities and Exchange Commission (the "SEC"). The Company intends to use the net proceeds it receives from the offering for general corporate purposes, including funding a portion of the construction costs of its Arkansas bromine project...
Snipp Interactive Reports Q1 2026 Financial Results; Bookings Backlog Reaches Record $20.6 Million; Announces Conference Call on Wednesday, June 3, 2026
VANCOUVER, BC / ACCESS Newswire / June 2, 2026 / Snipp Interactive Inc. ("Snipp" or the "Company") (TSXV:SPN)(OTCPK:SNIPF), a value-added, AI-powered SaaS company delivering "Marketing Verified from Ad to Aisle," today announced its financial results for the three months ended March 31, 2026 ("Q1 2026"). All results are reported under International Financial Reporting Standards ("IFRS") and in U.S. dollars...
ASCO 2026 | Updated Data from an Oral Presentation of InnoCare's Novel BCL2 Inhibitor Mesutoclax in MDS and AML Released
BEIJING, June 02, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that updated data from the Company's novel BCL2 inhibitor mesutoclax in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) has been released at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting as an oral presentation titled “Safety, tolerability, and efficacy of mesutoclax (ICP-248) in combination with azacitidine in patients with myeloid malignancies”, demonstrating outstanding efficacy and safety. As of April 20, 2026, among evaluable treatment-naïve (TN) MDS patients, the overall response rate (ORR) per IWG 2006 criteria was 100%, including a complete response (CR) rate of 40%, and marrow CR rate of 60%...
WuXi Biologics Named to CDP Supplier Engagement Assessment A List for the Second Consecutive Year
SHANGHAI, June 2, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has been named to the CDP Supplier Engagement Assessment (SEA) A List for the second consecutive year. The recognition highlights the company's leadership in engaging suppliers on climate-related issues and reflects its strong performance in governance, target-setting, Scope 3 emissions disclosure, and value chain engagement...
Cemex Announces Pricing of U.S.$1.5 Billion of 5.750% Senior Notes Due 2036
MONTERREY, Mexico--(BUSINESS WIRE)--Cemex, S.A.B. de C.V. (“Cemex”) (NYSE: CX) announced today the pricing of U.S.$1.5 billion of its 5.750% Senior Notes due 2036 (the “Notes”). The Notes will be guaranteed by Cemex's subsidiary, Cemex Corp. The Notes will bear interest semi-annually at an annual rate of 5.750% and mature on June 5, 2036. The Notes will be issued at a price of 99.572% of face value. The date of issuance of the Notes is scheduled to occur on June 5, 2026, subject to satisfaction...
PGIM Announces Net Asset Value Restatement for Three Exchange-Traded Funds (PAB, PSDM, PTRB)
NEWARK, N.J.--(BUSINESS WIRE)--This restatement is the result of an accounting error in calculating each exchange-traded fund's NAV by a third-party administrator.
Abivax Investigation Initiated: SueWallSt Investigates the Officers and Directors of Abivax (ABVX)
Jefferies downgraded Abivax from Buy to Hold and slashed its price target by nearly 44% after rare cancer cases emerged in the company's Phase 3 ulcerative colitis trial -- shares more than 40% of their value in a single session. NEW YORK, June 2, 2026 /PRNewswire/ -- Abivax (NASDAQ: ABVX) shareholders more than to 40% of their investment value on June 2, 2026, as the stock plunged from a pre-announcement close of approximately $129.69 to as low as $71 per share midday after rare malignancy cases surfaced in the company's Phase 3 ABTECT ulcerative colitis trial for obefazimod...
Astera Labs Expands Taiwan Operations to Accelerate Global AI Infrastructure Buildout
TAIPEI, Taiwan, June 03, 2026 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced a significant expansion of its Taiwan operations and Cloud-Scale Interop Lab, deepening the company's engineering, operational footprint, and strategic coordination with customers and ecosystem partners in one of the world's most important semiconductor ecosystems. As AI labs race to stand up training and inference capacity for frontier models, time-to-deployment increasingly depends on how quickly silicon, systems, and manufacturing partners can qualify designs, resolve issues, and move platforms into production...
HGV Announces Pricing of Secondary Public Offering of Common Stock and Concurrent Share Repurchase
ORLANDO, Fla.--(BUSINESS WIRE)--Hilton Grand Vacations Inc. (NYSE:HGV) (“HGV” or the “Company”) today announced the pricing of the previously announced secondary public offering (the “offering”) of 5,000,000 shares of the Company's common stock held by certain entities managed by affiliates of Apollo Global Management, Inc. (the “Selling Stockholders”). The offering is expected to close on June 4, 2026, subject to satisfaction of customary closing conditions. The underwriters will have a 30-day...
Netris Expands NVIDIA DSX Air and Network Automation Integration Across APAC AI Infrastructure
SANTA CLARA, Calif. & TAIPEI, Taiwan--(BUSINESS WIRE)-- #AIinfrastructure--Netris expands NAAM — Network Automation, Abstraction, & Multi-Tenancy — on NVIDIA DSX Air across APAC, as the AI infrastructure buildout accelerates.
Hydreight Announces Refiling of Interim Financial Statements
VANCOUVER, BC and LAS VEGAS, June 2, 2026 /PRNewswire/ - Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a U.S.-focused digital health infrastructure platform, announces that it has refiled its condensed interim consolidated financial statements for the three months ended March 31, 2026 and 2025 on SEDAR+ to correct classification errors contained within the segment financial information and disaggregation of revenue disclosures included in Note 16 – Operating Segments, relating to pharmacy sales within the Mobile Medical Services and Virtual Healthcare – Direct to Consumer segments. The Company has also made certain other immaterial administrative edits...
CAPREIT Announces Results of 2026 Annual Meeting
Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, June 02, 2026 (GLOBE NEWSWIRE) -- Canadian Apartment Properties Real Estate Investment Trust (TSX:CAR.UN) (“CAPREIT”) announced today that, at its Annual Meeting of Unitholders held today (the “Meeting”), each of the items of business referred to in its management information circular dated April 9, 2026 (the “Circular”) were passed by a vote held by ballot...
Figure Technology Solutions Reports May 2026 Operating Data
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Figure Technology Solutions (Nasdaq: FIGR; OPEN: FGRS), the leading blockchain-native capital marketplace for the origination, funding, sale, and trading of tokenized assets, today reported select preliminary operating data for the month ended May 31, 2026...
Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information And Announces Its Net Asset Value And Asset Coverage Ratios As Of May 31, 2026
HOUSTON, June 02, 2026 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of May 31, 2026...
Ayar Labs Joins NVIDIA NVLink™ Fusion Ecosystem to Bring Co-Packaged Optics to Rack-Scale AI Infrastructure
SAN JOSE, Calif.--(BUSINESS WIRE)--Ayar Labs, the leader in co-packaged optics (CPO) solutions for AI scale-up, announced it has joined the NVIDIA NVLink Fusion ecosystem, and making its products optically and electrically compatible with NVIDIA optical and SerDes technologies. This allows hyperscalers and system innovators to build optically-connected AI infrastructure around NVIDIA's NVLink Fusion platform and partner ecosystem. As AI factories scale to larger GPU counts and increasingly hete...
Backblaze Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO--(BUSINESS WIRE)--Backblaze, Inc. (Nasdaq: BLZE) today announced that on May 28, 2026, it granted an equity inducement award to Anuj Kumar, the Company's Chief Revenue Officer, as a material inducement to Mr. Kumar's employment with the Company. Mr. Kumar brings over two decades of experience scaling cloud revenue organizations at enterprise infrastructure companies, notably driving NetApp's worldwide cloud business during a period of significant growth. He joins Backblaze as the...
Obsidian Energy Announces Strategic Belly River Acquisition
Calgary, Alberta--(Newsfile Corp. - June 2, 2026) - OBSIDIAN ENERGY LTD. (TSX: OBE) (NYSE American: OBE) ("Obsidian Energy", the "Company", "we", "us" or "our") announced today the acquisition of high-return Belly River light oil assets in the Wilson Creek area of Willesden Green (the "Acquisition"), consolidating the Company's position as the largest Belly River producer and deepening our core light oil development platform...
Lightmatter Joins NVIDIA NVLink Fusion and Powers Next-Generation AI Infrastructure with Photonic Interconnects
TAIPEI, Taiwan--(BUSINESS WIRE)--Lightmatter, the leader in photonic (super)computing, today announced it has joined the NVIDIA NVLink Fusion ecosystem to accelerate the deployment of high-performance optical connectivity for AI infrastructure. Through this collaboration, Lightmatter will deliver Co-Packaged Optics (CPO) and Near-Packaged Optics (NPO) products that are compatible with NVIDIA's optical and SerDes technologies. By adapting Lightmatter's bi-directional optical link architecture fo...
DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy
Châtillon, France, June 2, 2026 DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy The study is evaluating the efficacy and safety of the VIASKIN Peanut Patch in achieving ad lib consumption of dietary peanut in infants ages 6 through 12 months with peanut allergy First participant screened by Dr. Douglas Mack, Assistant Clinical Professor in the Department of Pediatrics at McMaster University, Ontario DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a late-stage biopharmaceutical company, today announced that the first participant has been screened in the THRIVE Phase 2 clinical study evaluating the efficacy and safety of the VIASKIN Peanut Patch in achieving ad lib consumption of dietary peanut in infants ages 6 through 12 months in achieving ad lib consumption of dietary peanut. “Recent studies such as the LEAP trial, suggest there is a critical period, or ‘window of opportunity', in food allergy treatment during which early interventions may influence the trajectory of the allergy, its management, and long-term outcomes,” said Dr. Douglas Mack, Assistant Clinical Professor in the Department of Pediatrics at McMaster University and a principal investigator of THRIVE, “Given the higher immune plasticity associated with younger patients, we are very pleased this first-of-its kind study assessing the efficacy and safety of the VIASKIN Peanut Patch in this very young population is now underway...
Ionik Provides Update on Historical Acquisition-Related Debt Amendments and Assignments, a Historical Loan, and Its Previously Announced Debt Reorganization
Toronto, Ontario--(Newsfile Corp. - June 2, 2026) - Ionik Corporation (TSXV: INIK) (OTCQB: INIKF) (the "Company") wishes to provide an update to its May 22, 2026 announcement regarding the 30-day extension (the "Facility Extension") to its syndicated debt facility (the "Current Debt Facility"), comprehensive debt reorganization (the "Debt Reorganization") and the Company's anticipated entrance into a new senior debt facility (the "New Facility"), which is expected to replace the Current Debt Facility. The Facility Extension extends the maturity date of the Current Debt Facility from May 25, 2026 to June 25, 2026 and has been secured solely to permit completion of the Debt Reorganization and New Facility...
Janus Living Announces Pricing of Public Offering of Class A-1 Common Stock
DENVER--(BUSINESS WIRE)--Janus Living, Inc. (NYSE: JAN) (“Janus Living”), a pure-play senior housing real estate investment trust (REIT), announced today the pricing of its public offering of 25,000,000 shares of its Class A-1 common stock at a price to the public of $25.00 per share. In addition, Janus Living has granted the underwriters a 30-day option to purchase up to an additional 3,750,000 shares of its Class A-1 common stock at the public offering price, less the underwriting discount. T...
TVI Announces Filing of Annual Financials
Calgary, Alberta--(Newsfile Corp. - June 2, 2026) - TVI Pacific Inc. (TSXV: TVI) (OTC Pink: TVIPF) ("TVI" or the "Corporation") is pleased to report that it filed its annual audited financial statements, annual management's discussion and analysis, and related certifications for the year ended December 31, 2025 (the "Required Filings") on June 2, 2026. The Corporation's interim unaudited financial statements, interim management's discussion and analysis, and related certifications for the three-month period ended March 31, 2026 (collectively, the "Interim Filings") remain outstanding and are expected to be filed on or before June 12, 2026...
KIA AMERICA AND HYUNDAI MOTOR GROUP METAPLANT AMERICA CELEBRATE PRODUCTION OF THE 2027 KIA SPORTAGE HYBRID
IRVINE, Calif., June 2, 2026 /PRNewswire/ -- Today Hyundai Motor Group Metaplant America (HMGMA) and Kia America (KUS) celebrated the start of production for its newest vehicle, marking three major milestones for the advanced manufacturing facility: the first Kia model, the first hybrid electric vehicle (HEV), and the third vehicle to be assembled1 at the site...
Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026 Congress and Published in the New England Journal of Medicine
- The INDIGO study met its primary and all key secondary endpoints with statistically significant results - - Obexelimab significantly lowered the total amount of glucocorticoid use and reduced glucocorticoid-related toxicities - - A Biologics License Application (BLA) for obexelimab in IgG4-RD was submitted to the FDA in May - WALTHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today announced the presentation of additional positive data from the Phase 3 INDIGO trial evaluating obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD) at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, held from June 3-6, 2026, in London, England and published online by the New England Journal of Medicine...
Gensource Potash Announces Completion of Shares for Debt Transaction
Saskatoon, Saskatchewan--(Newsfile Corp. - June 2, 2026) - Gensource Potash Corporation (TSXV: GSP) ("Gensource" or the "Company"), a fertilizer development company focused on sustainable potash production, is pleased to announce that pursuant to debt settlement agreements previous announced on May 25, 2026 between the Company and four directors of the Company (the "Creditors"), the Company has issued 9,866,668 common shares in the capital stock of the Company ("Common Shares") at a deemed price of $0.15 per Common Share in full payment of $1,480,000 in outstanding unsecured, non-interest bearing promissory notes owing by the Company to the Creditors (the "Shares for Debt Transaction"). The issuance of the Common Shares to the Creditors, insiders of the Company, is considered a "related party transaction" within the meaning of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101")...
Hormel Foods Corporation to Participate in Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference
AUSTIN, Minn., June 2, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE: HRL), a Fortune 500 global branded food company, announced today that John Ghingo, president, and Paul Kuehneman, interim chief financial officer and controller, will participate in a fireside chat at the virtual Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference on Monday, June 8, 2026...
Apollo Funds Complete Sale of ALTEMIRA, Leading Pan-Asian Aluminum Packaging Company
TOKYO and NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) announced that Apollo-managed funds (the “Apollo Funds”) completed the sale of their interest in ALTEMIRA Holdings Co., Ltd. (“ALTEMIRA” or the “Company”), a leading pan-Asian aluminum packaging company, to funds managed by MBK Partners...
REMINDER: FS KKR Capital Group Investors With Significant Losses Must Act By July 6, 2026
NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds FS KKR Capital Group (“FS KKR Capital” or the “Company”) (NYSE:FSK) investors of the July 6, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as...
Encina and BASF Advance Long-Term Strategic Collaboration for Global Circular Chemicals Expansion
HOUSTON--(BUSINESS WIRE)--Encina Development Group, LLC (“Encina”), an ISCC PLUS certified producer of circular chemicals derived from waste streams, today announced the execution of a strategic Collaboration Agreement with BASF supporting the development of Encina's planned United States Gulf Coast circular chemicals manufacturing facility. The Collaboration Agreement sets the framework for BASF to provide strategic advisory support services during the key project development phases, leading u...
Maxim Power Corp. Announces Annual General Meeting Election Results
CALGARY, Alberta, June 02, 2026 (GLOBE NEWSWIRE) -- Maxim Power Corp. ("MAXIM" or the "Corporation") (TSX: MXG) announced today the final director election results from its 2026 annual general meeting of shareholders held on June 2, 2026 (the “Meeting”). A ballot was conducted at the Meeting with respect to the election of the directors to hold office until the next annual meeting of shareholders. According to the proxies received and ballots cast, the following directors were elected at the Meeting to hold office until the next annual meeting of shareholders or until their successors are elected or appointed, unless such office is earlier vacated in accordance with the by-laws of the Corporation:
Knicks Announce Exclusive Fundraiser for Two Celebrity Row Seats to Benefit the Garden of Dreams Foundation for Game 3 of 2026 NBA Finals
NEW YORK--(BUSINESS WIRE)--Madison Square Garden Sports Corp. (“MSG Sports”) announced today that the New York Knicks will auction off two Celebrity Row seats to benefit the Garden of Dreams Foundation for Game 3 of the NBA Finals. The fundraiser will begin Thursday, June 4 at Noon with details to come on Knicks.com/celebrityrowauction. Proceeds from the fundraiser will go to the Garden of Dreams Foundation. “The Garden of Dreams Foundation is the most important work that we do at the Madison S...
AmperCap Acquisition Company Announces the Pricing of $125,000,000 Initial Public Offering
New York, NY, June 02, 2026 (GLOBE NEWSWIRE) -- AmperCap Acquisition Company (the “Company”) announced today the pricing of its initial public offering of 12,500,000 units, at a price of $10.00 per unit. The units are expected to be listed on The Nasdaq Stock Market LLC (“Nasdaq”) and begin trading on Wednesday, June 3, 2026, under the ticker symbol “APMCU.” Each unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share upon the consummation of the Company's initial business combination. Once the securities constituting the units begin separate trading, the ordinary shares and rights are expected to be listed on Nasdaq under the symbols “APMC” and “APMCR,” respectively. The offering is expected to close on June 4, 2026, subject to customary closing conditions. The Company has granted the underwriters a 45-day option to purchase up to an additional 1,875,000 units at the initial public offering price to cover over-allotments, if any...
Sigma Lithium Demonstrates Excellence in Environmental Performance Filing Data Collected by External Experts Measuring Low Noise, Low Dust, Low Vibrations
HIGHLIGHTS Sigma Lithium files one year of external expert environmental data (for the 12 months to May 2026) demonstrating its track record: low levels of dust, vibrations, noise, monitored in four neighbouring communities, as follows: Dust: Sigma Lithium operates 560% better than recommended standards for total suspended particles, 350% better for particle size of below 2.5 micrometers. Noise: 95 measurement campaigns conducted during night and day demonstrated compliance with ABNT standards...
Endeavour Silver Announces 2026 Annual General Meeting Voting Results
VANCOUVER, British Columbia, June 02, 2026 (GLOBE NEWSWIRE) -- Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) is pleased to announce that shareholders voted in favour of all items of business at the Company's 2026 Annual General Meeting (“AGM”) held on June 2, 2026 in Vancouver. A total of 161,451,593 votes were cast or represented by proxy at the AGM, representing 54.53% of the outstanding common shares as of the record date. The following is a tabulation of the votes submitted by proxy:
Cotality Joins Snowflake Initiative to Define Standards for Agentic AI Financial Services Through the Open Semantic Interchange (OSI)
IRVINE, Calif.--(BUSINESS WIRE)--Cotality joined Snowflake's OSI Financial Services Working Group to eliminate data friction and provide standardized, AI-ready datasets for agents.
Did SoundHound AI, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Did Skyworks Solutions, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Did Monolithic Power Systems, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
CopperTech Metals Announces Public Filing of Registration Statement for Proposed Initial Public Offering
NEW YORK--(BUSINESS WIRE)--CopperTech Metals Inc. ("CopperTech" or the "Company") today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. CopperTech intends to list its common stock on the New York Stock Exchange, under the symbol “C...
Medallion Financial Corp. Urges Shareholders to Vote for Proven Performance
ISS and Glass Lewis Recognize Medallion's Successful Business Transformation Analysis Fails to Consider ZimCal's Ideas And Risks of Replacing Any of the Proven Incumbents with Its Nominees Medallion Also Highlights Eric Kelly's Alleged Financial Improprieties and History of Value Destruction NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Medallion Financial Corp. (NASDAQ: MFIN) (“ Medallion ” or the “ Company ”) today issued the following statement in connection with its 2026 Annual Meeting of Stockholders expressing strong disagreement with certain recommendations issued by ISS and Glass Lewis. The Company is facing its third consecutive proxy contest against ZimCal Asset Management LLC and its affiliates (collectively, “ ZimCal ”), a debtholder who promised in February 2024 to run a proxy contest “every year” unless the Company agreed to its demands to repurchase its debt at a substantial above market premium...
Lotus opens orders for Eletre X in mainland Europe
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (Nasdaq: LOT) (“Lotus Tech” or the “Company”), a leading global intelligent and luxury mobility provider, today introduced Eletre X (known as For Me in China), the first vehicle built on the brand's proprietary X-Hybrid architecture. The car is available to order now in mainland Europe2, starting from €96,990, and customer deliveries are expected from Q4 2026...
Stingray Receives Exemptive Relief to Facilitate Investment by Non-Canadians
MONTREAL, June 02, 2026 (GLOBE NEWSWIRE) -- Stingray Group Inc. (“Stingray” or the “Corporation”) (TSX: RAY) today announced that it has received an exemption to treat Stingray's subordinate voting shares and variable subordinate voting shares as a single class for certain purposes, including for applicable take-over bid and early warning reporting requirements under Canadian securities laws. Stingray applied for the exemption, which is effective immediately, to facilitate investment in its variable subordinate voting shares by non-Canadians...
Tecsys Announces 2026 Supply Chain Excellence Award Winners
Healthcare and distribution leaders recognized for advancing operational performance, resilience and innovation NASHVILLE, Tenn., June 2, 2026 /PRNewswire/ -- Tecsys Inc. (TSX: TCS), an industry-leading supply chain management company, today announced the winners of its 2026 Supply Chain Excellence Awards at the Tecsys User Conference (TUC) in Nashville, Tennessee...
Fortrea to Attend Jefferies Global Healthcare Conference
DURHAM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that that CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor Relations, Tracy Krumme will participate in the following conference:
Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
Also Announces Marketing Program VANCOUVER, BC / ACCESS Newswire / June 2, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H) (WKN: A3EKSZ) ("Onco" or the "Company") announces, further to its news release dated May 19, 2026, the successful advancement of kilogram-scale manufacturing activities for the B4 precursor component supporting the development of ONC010, the Company's lead nanoparticle-formulated Polynucleotide Kinase Phosphatase (PNKP) Inhibitor Technology. The milestone was achieved through the Company's ongoing chemistry, manufacturing and controls (CMC) collaboration with Dalton Pharma Services and represents an important step in scaling the manufacturing process required to support future formulation development, engineering batches, GMP production and planned clinical studies...
Champion Homes Announces Senior Leadership Appointments Across Customer Experience, Sales and Manufacturing
TROY, Mich.--(BUSINESS WIRE)--Champion Homes, Inc. (NYSE: SKY) (“Champion Homes”) today announced several leadership appointments in connection with the retirement of Joseph Kimmell, Executive Vice President, Operations, effective June 26, 2026. Mr. Kimmell will remain available on a consulting basis through the end of August to help ensure a smooth transition. The following appointments reflect the Company's planned approach to succession and leadership alignment as Champion continues to evolv...
Pershing Square Announces Quarterly Investor Communications Format to Begin with Second Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--Pershing Square Inc. (NYSE:PS) (“Pershing Square” or the “Company”) today announced its quarterly investor communications format. Following each fiscal quarter, beginning with the second quarter of 2026, on the same day, Pershing Square plans to: Earnings Release. Pershing Square plans to release its quarterly financial results before the opening of trading on the New York Stock Exchange. A portfolio company review will also be published concurrently with the publicat...
Pershing Square Holdings, Ltd. Notes Additional Quarterly Communications
LONDON--(BUSINESS WIRE)--Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) today announced that beginning with the second quarter 2026, Pershing Square Inc. (NYSE:PS), the parent company of PSH's Investment Manager, will increase the frequency and depth of its investor communications. Each quarter, Pershing Square Inc. will release its financial results and host an earnings webcast and conference call with analysts. Concurrently with the release of Pershing Square Inc.'s results, PSH will publi...
Pershing Square USA, Ltd. Notes Quarterly Communications Format
NEW YORK--(BUSINESS WIRE)--Pershing Square USA, Ltd. (NYSE:PSUS) (“PSUS” or the “Company”) today announced that beginning with the second quarter 2026, Pershing Square Inc. (NYSE:PS), the parent company of PSUS's Investment Manager, will release its financial results and host an earnings webcast and conference call with analysts. Concurrently with the release of Pershing Square Inc.'s results, PSUS will publish a quarterly portfolio review. Immediately following the Pershing Square Inc. earning...
Ubisoft Reveals Rayman Legends Retold, Available on October 1
SAN FRANCISCO--(BUSINESS WIRE)--Today, during Sony's State of Play, Ubisoft announced Rayman Legends Retold, a reimagining of the classic platformer. Rayman Legends Retold will launch on October 1 on Ubisoft+*, PlayStation5, Xbox Series X|S, Nintendo Switch 2™, GeForce Now, Blacknut, and PC through Ubisoft Connect, Steam, and the Epic Games Store...
KBRA Assigns Preliminary Ratings to Pagaya AI Debt Grantor Trust 2026-4 and Pagaya AI Debt Trust 2026-4
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings to 13 classes of notes issued by Pagaya AI Debt Grantor Trust 2026-4 and Pagaya AI Debt Trust 2026-4, collectively “PAID 2026-4,” an unsecured consumer loan ABS transaction. PAID 2026-4 has initial hard credit enhancement levels ranging from 83.97% for the Class A-1 Notes to 4.05% for the Class F-2 Notes. Credit enhancement is comprised of overcollateralization, subordination, except for the Class F-2 Notes, cash reserve accounts funde...
Afya Limited (the "Company") Notice of Annual General Meeting of the Company
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Notice is hereby given that an Annual General Meeting of the Company (the "AGM") will be held at the offices of Afya Participações S.A., Rua Paraíba, No. 330, 17th Floor, Bairro Funcionários, Belo Horizonte, Minas Gerais, 30130-917, Brazil, and virtually by accessing the following link https://edge.media-server.com/mmc/p/ej9nfse2 (password: afya2026), on the 22nd day of June 2026 at 10:00 a.m. BRT, for the purpose of considering and, if thought fit, pass...
Canlan Sports and Entripy Custom Clothing Announce Naming Rights Agreement for Oakville Facility
Canlan Sports Oakville officially renamed "Entripy Centre - A Canlan Sports Community" effective June 1, 2026 Toronto, Ontario--(Newsfile Corp. - June 2, 2026) - Canlan Ice Sports Corp. (TSX: ICE) ("Canlan Sports") and Entripy Custom Clothing, Canada's leading destination for custom apparel, today announced a landmark naming rights agreement that will see Canlan Sports Oakville renamed the Entripy Centre - a Canlan Sports Community . The agreement includes prominent Entripy branding throughout the sports complex's interior and exterior, effective immediately...
Dorman Products, Inc. Announces Pricing of $450 Million Senior Notes Offering
COLMAR, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ: DORM), a leading supplier in the motor vehicle aftermarket industry, announced today that it priced its private offering of $450.0 million aggregate principal amount of 6.25% senior notes due 2034 (the “Notes”) at an issue price of 100.000%. The sale of the Notes is expected to close on June 16, 2026, subject to customary closing conditions...
Trisura Group Announces Results of Annual Meeting of Shareholders
TORONTO, June 02, 2026 (GLOBE NEWSWIRE) -- Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU) today announced the results of the Company's virtual annual meeting of shareholders held on June 2, 2026 in Toronto (the “Meeting”).
Betterware de México Completes Acquisition of Tupperware's Operations in Latin America
GUADALAJARA, Mexico--(BUSINESS WIRE)--Betterware de México, S.A.P.I. de C.V. (NYSE: BWMX) (“BeFra” or the “Company”), the parent company of Betterware and Jafra, today announced the successful completion of its previously announced acquisition of 100% of the Tupperware brand's operating assets in Latin America, primarily in Mexico and Brazil (“Tupperware Latin America”), together with a perpetual, royalty-free, and exclusive license to the “Tupperware” brand for the entire LatAM region1. The cl...